68-Gallium DOTATATE

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

68-Gallium DOTATATE
Treatment and conditionWhere it standsTrials
68-Gallium DOTATATE for neuroectodermal tumors, primitivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
68-Gallium DOTATATE for neuroendocrine tumorsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1